Invasive aspergillosis in severely neutropenic patients over 18 years: impact of intranasal amphotericin B and HEPA filtration
- 1 January 1998
- journal article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 38 (1) , 11-18
- https://doi.org/10.1016/s0195-6701(98)90170-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcomeThe American Journal of Medicine, 1994
- Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patientsAntimicrobial Agents and Chemotherapy, 1994
- Aerosol amphotericin B for prevention of invasive pulmonary aspergillosisAntimicrobial Agents and Chemotherapy, 1993
- Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell TransplantsInfection Control & Hospital Epidemiology, 1993
- Prevention of nosocomial aspergillosisJournal of Hospital Infection, 1991
- Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patientsThe American Journal of Medicine, 1991
- Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study.Journal of Clinical Oncology, 1991
- Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published CasesClinical Infectious Diseases, 1990
- Incidence of Nosocomial Aspergillosis in Patients with Leukemia Over a Twenty-Year PeriodInfection Control & Hospital Epidemiology, 1989
- An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adultsBlood, 1984